U.K., Sept. 28 -- South Korea's largest telecoms company has announced it is entering the country's digital healthcare market.
KT, formerly known as Korea Telecom, has signed a memorandum of understanding with NGeneBio, a local gene sequencing company. Together they will create personalised products based on gene data analysis.
Additionally KT is planning to work with Kazakhastan-based medical centre Medical Partners Korea to launch an information technology-based epidemic control system. It will launch in Kazakhastan this year and in Russia in 2021.
NGeneBio was founded in 2014 as an inhouse venture from KT. In 2015 it established a molecular laboratory, and the following year received approval to start genetic testing. The company ha...